Iradimed (IRMD) Gross Profit (2013 - 2026)

Iradimed (IRMD) has 14 years of Gross Profit data on file, last reported at $16.8 million in Q1 2026.

• Quarterly Gross Profit rose 13.28% year-over-year to $16.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.3 million (up 14.69% YoY) and the FY2025 annual result came in at $64.3 million, up 14.15% from the prior year.
• Gross Profit fell to $16.8 million in Q1 2026 per IRMD's latest filing, from $17.0 million in the prior quarter.
• Across five years, Gross Profit topped out at $17.0 million in Q4 2025 and bottomed at $9.4 million in Q1 2022.
• The 5-year median for Gross Profit is $13.4 million (2023), against an average of $13.5 million.
• The widest annual swing landed in 2022, when Gross Profit soared 38.29%; it then climbed 10.05% in 2024.
• Tracing IRMD's Gross Profit over 5 years: stood at $11.2 million in 2022, then climbed by 19.54% to $13.4 million in 2023, then grew by 10.05% to $14.8 million in 2024, then grew by 15.38% to $17.0 million in 2025, then decreased by 1.28% to $16.8 million in 2026.
• Per Business Quant, the three latest IRMD Gross Profit figures stand at $16.8 million (Q1 2026), $17.0 million (Q4 2025), and $16.5 million (Q3 2025).

Peer Comparison